Physician Assistant in Kanab, UT Accepting Medicare

3 Physician Assistant nurses found. Showing 1 - 3

Wayne S Nielson, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 355 N Main St, Kanab, UT 84741 Phone: 435-644-4179    Fax: 435-644-3588

Mark Overas, P.A.-C Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 355 N Main St, Kanab, UT 84741 Phone: 435-644-4100    Fax: 435-644-3366

Clinton T Dowse, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 355 N Main St, Kanab, UT 84741 Phone: 435-644-4100    Fax: 435-644-3366

News Archive

Treating volatile exhaust streams in the pharmaceutical industry: an interview with Jeff Kudronowicz

Capturing and destroying harmful emissions from pharmaceutical processes can be challenging. It's not because the pollutants, referred to as volatile organic compounds (VOCs) or hazardous air pollutants (HAPs) are difficult to destroy using catalytic or thermal technologies.

Debiopharm granted license to develop and commercialise CDC25

Ipsen, an innovation-driven global specialty pharmaceutical Group and Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, announced today the signature of an agreement under which Debiopharm is granted an exclusive worldwide license to develop and commercialise Ipsen's first-in-class inhibitor of the CDC25 phosphatase enzyme (now Debio 0931), for the treatment of various human cancers.

Rhei granted marketing approval for MuGard in China

ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, diabetes, and RNAi, announced that its MuGard partner in China, Rhei Pharmaceuticals HK Ltd., received regulatory and marketing approval for MuGard in China from the State Food and Drug Administration, or SFDA, to treat oral mucositis in cancer patients.

Bristol-Myers Squibb awards 3 new grants to enhance HBV and HCV prevention, diagnosis and care

The Bristol-Myers Squibb Foundation has awarded three new grants to improve prevention, diagnosis and care of hepatitis B (HBV) and hepatitis C (HCV) in China and India as part of its Delivering Hope: Awareness, Prevention and Care umbrella program which is committed to reducing hepatitis-related health disparities in Asia.

Study finds major sex differences when considering link between psoriasis and metabolic disorders

An analysis published in the Journal of the European Academy of Dermatology and Venereology revealed considerable sex differences when considering links between psoriasis and metabolic disorders.

Read more Medical News

› Verified 4 days ago